EIT Health, in partnership with Tronico and the University Hospital of Nantes (CHU Nantes), has initiated its second challenge and is actively seeking a groundbreaking solution to enhance the detection and management of sexually transmitted infections. The objective is to decrease the incidence of infections and improve the delivery of appropriate treatment for all populations.
We are looking for solutions that solve the following challenges:
a) Sample collection and detection of STI pathogens – We need a new medical device, either standalone or integrated (class I or II), to detect infections such as Chlamydia trachomatis and Neisseria gonorrhoeae. It should meet or exceed sensitivity and specificity levels advised by HAS using nucleic acid amplification tests (NAATs), including the Ct/NG duplex for co-infection screening. The device should be user-friendly for easy access and quick results, possibly with auto-sampling. Additionally, a control test for each sample would be appreciated, particularly to confirm the presence of human material.
b) Results informing patient and healthcare professional decisions – We’re looking for an innovative tool that helps patients make decisions about their healthcare, focusing on diagnostics and treatment. The tool should seamlessly integrate into existing processes for easy access to treatment. It should also allow sharing of data with healthcare professionals to guide treatment strategies, such as choosing antibiotics considering the challenge of antibiotic resistance.
